Pioglitazone, Not Rosiglitazone, Again Tied to Bladder CancerPioglitazone, Not Rosiglitazone, Again Tied to Bladder Cancer

"Substantial and fairly consistent" evidence points to pioglitazone as associated with increased risk of bladder cancer, and this study strengthens and "confirms" that evidence, an expert says. Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news